论文部分内容阅读
目的分析黄芪生脉饮辅助治疗病毒性心肌炎的效果。方法选取2015年4月至2016年11月时间段内的84例病毒性心肌炎患者,随机分成对照组(42例)和研究组(42例);对照组仅给予常规治疗,研究组在常规治疗基础上加用黄芪生脉饮辅助治疗,对比两组患者临床治疗效果。结果研究组治疗总有效率为92.8%,对照组为81.0%,研究组明显高于对照组,组间差异显著,具有统计学意义(P<0.05)。结论黄芪生脉饮辅助治疗病毒性心肌炎,效果显著,值得广泛推广。
Objective To analyze the effect of Astragalus Shengmai Yin in the treatment of viral myocarditis. Methods Eighty-four patients with viral myocarditis during the period from April 2015 to November 2016 were randomly divided into control group (n = 42) and study group (n = 42). The control group was given routine treatment only. The study group was treated with conventional therapy Based on the use of Astragalus Shengmai plus adjuvant therapy, the clinical efficacy of two groups were compared. Results The total effective rate was 92.8% in the study group and 81.0% in the control group, which was significantly higher in the study group than in the control group with significant difference (P <0.05). Conclusion Astragalus Sheng Mai Yin auxiliary treatment of viral myocarditis, the effect is significant, it is worth widely disseminated.